Originally Posted by
silverblizzard888
Not the outcome many were looking for from the FDA, but given everyone thought it would be a short term supply anyway it wasn't a big loss by this outlook (though of course it dashes the long term potential many hoped A2 would have in the US), though with the international market opening up again, overall sentiment for A2 is positive.
Share price has been sold down in panic, but has bounced back a little for those who realise the overall picture and value the company still has.